Valuation: Omnicell, Inc.

Market Cap 1.62B 1.39B 1.29B 1.19B 2.23B 155B 2.27B 15.35B 5.98B 77.65B 6.08B 5.95B 257B P/E 2026 *
36.1x
P/E 2027 * 35x
Enterprise Value 1.62B 1.39B 1.29B 1.19B 2.23B 155B 2.27B 15.35B 5.98B 77.65B 6.08B 5.95B 257B EV / Sales 2026 *
1.31x
EV / Sales 2027 * 1.26x
Free-Float
76.4%
Yield 2026 *
-
Yield 2027 * -
1 day+0.15%
1 week-4.05%
Current month+1.19%
1 month-14.44%
3 months-18.21%
6 months-9.53%
Current year-20.99%
1 week 35.17
Extreme 35.17
37.3
1 month 34.86
Extreme 34.86
44.27
Current year 31.75
Extreme 31.75
55
1 year 29.06
Extreme 29.06
55
3 years 22.66
Extreme 22.66
61.44
5 years 22.66
Extreme 22.66
187.28
10 years 22.66
Extreme 22.66
187.28
Manager TitleAgeSince
Chief Executive Officer 68 01/10/2002
Director of Finance/CFO 56 15/09/2025
President 50 01/07/2026
Director TitleAgeSince
Chairman 68 01/09/1992
Director/Board Member 70 01/01/2013
Director/Board Member 70 01/01/2014
Date Insider Type Main position Quantity % Market Cap.
17/8/26 Sell

Chairperson

-3,083 0.0068%
15/8/26 Tax

Chief Executive Officer

-12,350 0.0272%
15/8/26 Tax

Chief Administrative Officer

-4,025 0.0089%
Change 5-day change 1-year change 3-year change Capi.($)
+0.15%-4.05%+12.23%-38.23% 1.62B
-0.47%+1.87%-12.04%+32.03% 40.7B
-6.99%+4.29%-37.71%+173.32% 15.32B
-0.89%-0.71%-20.61%+67.08% 5.73B
+5.92%+16.59%+69.58% - 4.07B
+1.47%+3.77% - - 2.05B
-3.58%+18.29%-28.96% - 1.23B
+9.96%+11.46%+45.39%+153.90% 944M
-0.96%-3.13%+653.66%+896.77% 821M
-2.27%-5.99%-37.50%-46.92% 813M
Average +0.22%+8.44%+71.56%+176.85% 7.33B
Weighted average by Cap. -1.40%+5.41%-5.18%+77.72%

Financials

2026 *2027 *
Net sales 1.24B 1.06B 988M 907M 1.7B 118B 1.74B 11.72B 4.57B 59.31B 4.64B 4.54B 196B 1.29B 1.1B 1.03B 944M 1.77B 123B 1.81B 12.21B 4.76B 61.78B 4.84B 4.73B 205B
Net income 45.27M 38.76M 36.17M 33.19M 62.36M 4.33B 63.59M 429M 167M 2.17B 170M 166M 7.19B 47.37M 40.56M 37.84M 34.72M 65.24M 4.53B 66.53M 449M 175M 2.27B 178M 174M 7.52B
Net Debt - -
Logo Omnicell, Inc.
Omnicell, Inc. is a healthcare technology provider focused on autonomous medication management, by unifying automation and AI-enabled intelligence, optimized by expert services, to drive clinical and business outcomes that are helping to improve efficiency and enhance patient safety for healthcare facilities. The Company is focused on helping its customers define and deliver a medication management strategy designed for pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. It provides a range of points of care medication and supplies dispensing systems, including automated systems and offers advanced automation solutions, including robotics designed to automate work, streamline workflows, and reduce human error. It provides central pharmacy automation solutions for both medication dispensing and IV compounding and provides patient engagement solutions.
Employees
3,485
Date Price Change Volume
21/08/26 US$35.78 +0.77% 112,184
20/08/26 US$35.50 -2.55% 582,107
19/08/26 US$36.43 +1.28% 667,427
18/08/26 US$35.97 -0.17% 947,786
17/08/26 US$36.03 -3.40% 887,407
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
35.50USD
Average target price
57.86USD
Spread / Average Target
+62.98%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. OMCL Stock